IE822064L - Composition containing human insulin and c-peptide - Google Patents

Composition containing human insulin and c-peptide

Info

Publication number
IE822064L
IE822064L IE822064A IE206482A IE822064L IE 822064 L IE822064 L IE 822064L IE 822064 A IE822064 A IE 822064A IE 206482 A IE206482 A IE 206482A IE 822064 L IE822064 L IE 822064L
Authority
IE
Ireland
Prior art keywords
peptide
human insulin
composition containing
containing human
human
Prior art date
Application number
IE822064A
Other versions
IE54119B1 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IE822064L publication Critical patent/IE822064L/en
Publication of IE54119B1 publication Critical patent/IE54119B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A pharmaceutical composition is disclosed which comprises, in association with a pharmaceutically acceptable carrier, human insulin and human C-peptide in a molar ratio, human insulin to human C- peptide, of from about 1:4 to about 4:1. [GB2104382A]
IE2064/82A 1981-08-27 1982-08-26 Pharmaceutical formulations comprising human insulin and human c-peptide IE54119B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
IE822064L true IE822064L (en) 1983-02-27
IE54119B1 IE54119B1 (en) 1989-06-21

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2064/82A IE54119B1 (en) 1981-08-27 1982-08-26 Pharmaceutical formulations comprising human insulin and human c-peptide

Country Status (20)

Country Link
JP (1) JPS5846024A (en)
AU (1) AU551879B2 (en)
BE (1) BE894185A (en)
CA (1) CA1176158A (en)
CH (1) CH650679A5 (en)
DE (1) DE3232034A1 (en)
DZ (1) DZ452A1 (en)
FR (1) FR2513126B1 (en)
GB (1) GB2104382B (en)
IE (1) IE54119B1 (en)
IL (1) IL66611A0 (en)
IT (1) IT1153182B (en)
LU (1) LU84359A1 (en)
MW (1) MW3882A1 (en)
NL (1) NL192192C (en)
NZ (1) NZ201682A (en)
PH (1) PH19361A (en)
SE (1) SE460334B (en)
ZA (1) ZA826159B (en)
ZW (1) ZW17482A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (en) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt PHARMACEUTICAL AGENT FOR TREATING THE DIABETES MELLITUS
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
FI882921A0 (en) * 1986-10-20 1988-06-17 Novo Industri As PROTAMINZINK-INSULINPREPARAT.
FI884914A0 (en) * 1987-02-25 1988-10-24 Novo Industri As NYA INSULINDERIVAT.
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
SE520392C2 (en) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specific peptides for the treatment of diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
ES2391776T3 (en) 2004-11-22 2012-11-29 Novo Nordisk A/S Soluble, stable formulations containing insulin with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
CA2798518A1 (en) 2010-05-17 2011-11-24 Cebix, Inc. Pegylated c-peptide
US8962553B2 (en) 2011-11-17 2015-02-24 Cebix Ab Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (en) * 1953-09-08 1958-05-31 British Drug Houses Ltd Process for the production of an insulin preparation with an extended duration of action

Also Published As

Publication number Publication date
IT8223017A0 (en) 1982-08-27
ZA826159B (en) 1984-04-25
DE3232034A1 (en) 1983-03-10
IE54119B1 (en) 1989-06-21
MW3882A1 (en) 1984-07-11
NL8203315A (en) 1983-03-16
SE460334B (en) 1989-10-02
DE3232034C2 (en) 1991-04-11
GB2104382A (en) 1983-03-09
FR2513126B1 (en) 1986-04-18
CA1176158A (en) 1984-10-16
FR2513126A1 (en) 1983-03-25
NZ201682A (en) 1985-08-16
IT8223017A1 (en) 1984-02-27
AU551879B2 (en) 1986-05-15
SE8204873D0 (en) 1982-08-25
GB2104382B (en) 1984-12-19
ZW17482A1 (en) 1982-11-17
SE8204873L (en) 1983-02-28
NL192192B (en) 1996-11-01
IT1153182B (en) 1987-01-14
BE894185A (en) 1983-02-24
AU8759482A (en) 1983-03-03
NL192192C (en) 1997-03-04
IL66611A0 (en) 1982-12-31
JPS5846024A (en) 1983-03-17
LU84359A1 (en) 1983-02-28
CH650679A5 (en) 1985-08-15
DZ452A1 (en) 2004-09-13
PH19361A (en) 1986-04-02

Similar Documents

Publication Publication Date Title
AU7200387A (en) Device for self-administration of physiologically active substances, with prevention of overdosing
AU7194691A (en) Therapeutic use of indole-3-yl-carboxylic acid endo-8- methyl-8-aza-bicyclo(3,2,1)oct-3-yl ester
AU588202B2 (en) Dosage form for delivering acid sensitive beneficial agent
AU4690379A (en) Administering intravenous drugs
AU6206686A (en) Insulin analogues and process for their preparation
IL92589A0 (en) Enzyme-inhibiting urea derivatives of dipeptides,a process for the preparation thereof,pharmaceutical compositions containing these,and the use thereof
IL77430A (en) 3-alkyl-and 3,8-dialkyl-6-thioxanthine and pharmaceutical compositions containing them
IE822064L (en) Composition containing human insulin and c-peptide
JPS6413070A (en) Novel compound, manufacture and medicinal composition
DE3662104D1 (en) 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments
AU549066B2 (en) Preparation of human insulin
DE2967337D1 (en) Antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives
AU610175B2 (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
AU7260091A (en) Insulin derivatives, a process for their preparation, and their use
AU8182187A (en) Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof
IE822062L (en) Human proinsulin formulations
CS203587A2 (en) Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation
SE8204872D0 (en) PHARMACEUTICAL PREPARATIONS, INCLUDING HUMAN INSULIN, HUMAN C-PEPTIDE AND HUMANT PROINSULIN
AU3474289A (en) Pharmaceutical solutions of triamterene
DE3664768D1 (en) 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives, preparation process and medicinal use
AU7596687A (en) 1,3-propanediamine derivatives, preparation and pharmaceutical compositions containing them
AU590217B2 (en) Naphthalene derivatives possessing a retinoid-type action, processes for their preparation, and medicinal and cosmetic compositions containing these derivatives
AU590217C (en) Naphthalene derivatives possessing a retinoid-type action, processes for their preparation, and medicinal and cosmetic compositions containing these derivatives
AU610074C (en) Therapeutic use of indol-3-yl-carboxylic acid endo-8-methyl- 8-aza-bicyclo{3,2,1}oct-3-yl ester
JPS545913A (en) Preparation of pantethine

Legal Events

Date Code Title Description
MK9A Patent expired